FDA’s Voluntary Malfunction Summary Reporting Program to Reduce Number of MDRs
Today FDA announced it has finalized the Voluntary Malfunction Summary Program, the goal of which is to streamline the way in which malfunctions are reported while still giving the agency enough information to effectively monitor devices. Eligible manufacturers would only have to submit certain medical device reports (MDRs) related to device malfunctions in summary form on a quarterly basis (for certain product codes).
The program is in line with goals negotiated under MDUFA IV to streamline malfunction reporting.
“The FDA believes that grouping events that are the same or similar into a single summary report description will benefit manufacturers, the FDA, and the public. This approach is expected to reduce the number of reports manufacturers need to submit to FDA by approximately two thirds, and continue to provide sufficient detail to monitor the safety of devices on the U.S. market.” – FDA
FDA has identified the eligible product codes in its product classification database. Product codes must have been in existence for at least two years to be eligible. Manufacturers can use the same electronic submission form that is used to submit individual MDRs.
More information about the program is available on the Federal Register.
Related Articles
-
The goal of the TAP Pilot is to reduce the time from concept to commercialization of medical devices by facilitating robust engagement early in the process with the FDA, industry and key stakeholders.
-
The voluntary program is designed to help companies advance alternative and innovative ways to sterilize approved medical devices, including changing radiation sources, in a least burdensome regulatory approach.
-
The FDA has issued three new draft guidances related to the 510(k) submissions program, including Best Practices for Selecting a Predicate Device, Use of Clinical Data in Premarket Notification and Evidentiary Expectations for Implant Devices. The agency is accepting comments…
-
“The MedAccred Labeling, Printing and UDI Task Group’s role is to provide medical device companies with structure and requirements to assist in identifying and implementing industry best practices for global market compliance.”
